Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Metastatic Prostate Cancer ◽

Growth Factor Receptor ◽

Cancer Specific Survival ◽

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0648 ◽

2007 ◽

Vol 6 (3) ◽

pp. 967-978 ◽

Cited By ~ 64

Author(s):

Murielle Mimeault ◽

Sonny L. Johansson ◽

Ganesh Vankatraman ◽

Eric Moore ◽

Jean-Pierre Henichart ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hedgehog Signaling ◽

Metastatic Prostate Cancer ◽

Growth Factor Receptor ◽

Prostate Cancer Cells ◽

Cytotoxic Effects ◽

Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6

Cancer Letters ◽

10.1016/j.canlet.2016.10.014 ◽

2017 ◽

Vol 384 ◽

pp. 1-8 ◽

Cited By ~ 12

Author(s):

Yuan-Chin Tsai ◽

Wei-Yu Chen ◽

Man Kit Siu ◽

Hong-Yuan Tsai ◽

Juan Juan Yin ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Tumor Suppressor ◽

Epidermal Growth Factor ◽

Metastatic Prostate Cancer ◽

Growth Factor Receptor ◽

Receptor Signaling ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-0103 ◽

2010 ◽

Vol 16 (4) ◽

pp. 1245-1255 ◽

Cited By ~ 44

Author(s):

P. Hammarsten ◽

A. Karalija ◽

A. Josefsson ◽

S. H. Rudolfsson ◽

P. Wikstrom ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Favorable Outcome ◽

Epidermal Growth ◽

Low Levels ◽

Malignant Prostate

1437: Evaluation of Epidermal Growth Factor Receptor and Urokinase-Type Plasminogen Activator Receptor in Serum of Prostate Cancer Patients

The Journal of Urology ◽

10.1016/s0022-5347(18)31638-0 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 474-475 ◽

Cited By ~ 1

Author(s):

Giulio Milanese ◽

Luca Gasparri ◽

Nicolai Sidenius ◽

Marta Canonici ◽

Marco Dellabella ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Type Plasminogen Activator ◽

Urokinase Type Plasminogen Activator ◽

Epidermal Growth ◽

Plasminogen Activator Receptor

263: Expression of Epidermal Growth Factor Receptor and Platelet-Derived Growth Factor Receptor in Prostate Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)32530-8 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 87-88

Author(s):

Chang Wook Jeong ◽

Cheol Kwak ◽

Gheeyoung Choe ◽

Sang Eun Lee

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Platelet Derived Growth Factor ◽

Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic

The Science of The Total Environment ◽

10.1016/j.scitotenv.2012.02.079 ◽

2012 ◽

Vol 424 ◽

pp. 74-78 ◽

Cited By ~ 9

Author(s):

Tzu-I Sung ◽

Ying-Jan Wang ◽

Chi-Yi Chen ◽

Tsui-Lien Hung ◽

How-Ran Guo

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Serum Level ◽

Liver Cancer ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer

Molecular and Cellular Endocrinology ◽

10.1016/j.mce.2013.11.017 ◽

2014 ◽

Vol 383 (1-2) ◽

pp. 69-79 ◽

Cited By ~ 11

Author(s):

Weijuan Wu ◽

Qing Yang ◽

Kar-Ming Fung ◽

Mitchell R. Humphreys ◽

Lacy S. Brame ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Aminobutyric Acid ◽

Human Prostate ◽

Human Prostate Cancer ◽

Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations

Thoracic Cancer ◽

10.1111/1759-7714.12365 ◽

2016 ◽

Vol 7 (5) ◽

pp. 543-548 ◽

Cited By ~ 4

Author(s):

Shuyang Yao ◽

Xiuyi Zhi ◽

Ruotian Wang ◽

Kun Qian ◽

Mu Hu ◽

...

Keyword(s):

Lung Cancer ◽

Retrospective Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Lung Cancer Patients ◽

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer

Molecular Cancer ◽

10.1186/s12943-018-0785-1 ◽

2018 ◽

Vol 17 (1) ◽

Cited By ~ 4

Author(s):

Yuan-Chin Tsai ◽

Tao Zeng ◽

Wassim Abou-Kheir ◽

Hsiu-Lien Yeh ◽

Juan Juan Yin ◽

...

Keyword(s):

Prostate Cancer ◽

Receptor Tyrosine Kinase Inhibitors

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Afatinib treatment in a large real‐world cohort of non‐small cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

International Journal of Cancer ◽

10.1002/ijc.33821 ◽

2021 ◽

Author(s):

Chi‐Hsien Huang ◽

Jia‐Shiuan Ju ◽

Tzu‐Hsuan Chiu ◽

Allen Chung‐Cheng Huang ◽

Pi‐Hung Tung ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽